Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

Ultrasound treatment could be safe and effective option for people with essential tremor

Ultrasound treatment could be safe and effective option for people with essential tremor

Movements affect the processing of visual stimuli

Movements affect the processing of visual stimuli

Scientists discover new molecular drivers of Parkinson's disease

Scientists discover new molecular drivers of Parkinson's disease

New glassy carbon electrode makes deep brain stimulation safer for patients

New glassy carbon electrode makes deep brain stimulation safer for patients

New light-based method to capture the epicenter of neural activity in the brain

New light-based method to capture the epicenter of neural activity in the brain

Researchers evaluate potential of FMT, pre- and probiotics to treat Parkinson's patients

Researchers evaluate potential of FMT, pre- and probiotics to treat Parkinson's patients

New insights into how immune system and inflammation play a role in PD

New insights into how immune system and inflammation play a role in PD

People who are illiterate may have greater risk of developing dementia

People who are illiterate may have greater risk of developing dementia

Targeting the formation of alpha-synuclein aggregates may slow Parkinson's progression

Targeting the formation of alpha-synuclein aggregates may slow Parkinson's progression

SleepFit app can help monitor motor symptoms in patients with Parkinson's disease

SleepFit app can help monitor motor symptoms in patients with Parkinson's disease

Understanding neural processes behind motor behaviours and learning

Understanding neural processes behind motor behaviours and learning

Scientists identify new mechanism for the development of Parkinson's disease

Scientists identify new mechanism for the development of Parkinson's disease

Fluorescent carbon dots can effectively detect calcium levels in cells

Fluorescent carbon dots can effectively detect calcium levels in cells

Parkinson's Foundation and Parkinson's UK form new partnership

Parkinson's Foundation and Parkinson's UK form new partnership

Future drugs aimed at halting cell-inactivation process may help prevent Parkinson's disease

Future drugs aimed at halting cell-inactivation process may help prevent Parkinson's disease

New recommendations aim to improve outcomes of Parkinson's disease patients

New recommendations aim to improve outcomes of Parkinson's disease patients

Researchers identify new factors associated with higher mortality rates in Parkinson's patients

Researchers identify new factors associated with higher mortality rates in Parkinson's patients

Does Parkinson's disease start in the brain or gut?

Does Parkinson's disease start in the brain or gut?

When caring for a sick spouse shakes a marriage to the core

When caring for a sick spouse shakes a marriage to the core